Global pharmaceutical market, 1999-2009
Sales are currently concentrated in developed markets, but growth is concentrated in emerging markets
Global pharmaceutical market forecast by therapy area, 2009-14
Top 12 pharmaceutical companies by revenue
Top 10 public biotech companies by revenue
Global challenges in drug development innovation
MNCs are facing massive near term patent expirations without replacements in the pipeline
Cost and time of developing a new drug have skyrocketed, as clinical development has become increasingly complex…
…and increasingly outsourcing and off-shoring R&D…
Reduced R&D focus is reflected in the increasing portion of industry revenues derived from in-licensed and acquired products
The ability to innovate is crucial as industry revenues are trending away from traditional technologies and towards biotech
Mid to late stage acquisitions have increased at the expense of early stage compounds
Opportunities to address global challenges
Despite big pharma’s innovation decline, healthcare spending as a percent of GDP is growing globally
…With healthcare spend in emerging markets increasing at twice the rate of the developed world
Emerging markets are positioned to serve the rising demand more efficiently…